Back

Hepatic involvement in metabolic syndrome: from assessment to therapeutic options

15 October 2026 (08:35 - 08:50)
Organised by:
Seminar Presentation Part of: Cardiovascular kidney metabolic syndrome: a holistic perspective Chronic Kidney Disease Open Access ESC in LATAM 2026

5 More presentations in this session

Presentation thumbnail
Cardiovascular disease and chronic kidney disease: insights from the new 2026 ESC guidelines
Presentation thumbnail
Cardiovascular disease and chronic kidney disease: insights from the new 2026 ESC guidelines - Panel Discussion
Presentation thumbnail
Management of insulin resistance and type II diabetes
Presentation thumbnail
Obesity management: understanding to treat
Presentation thumbnail
Panel discussion and final conclusions

Access the full session

Session thumbnail
Cardiovascular kidney metabolic syndrome: a holistic perspective

The Event

Event poster

ESC in LATAM 2026

15 October 2026 08:35 CET
You may be interested in
thumbnail
Congress Presentation
Hepatoprotective and cardioprotective effects of empagliflozin in spontaneously hypertensive rats fed a high-fat diet
21 May 2023
thumbnail
Congress Presentation
Digital therapautic effective in managing metabolic syndrome parameters
27 August 2021
thumbnail
Congress Session
The liver and the heart: addressing interdisciplinary cardiometabolic risk
30 August 2026
thumbnail
Congress Session
Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources